Mini DNA sequencer tests true

The performance of the MinION™ miniature DNA sequencing device has been evaluated by an open, international consortium, and the resulting recommendations and protocols published before peer-review on the F1000Research platform.

MinION™ USB-attached miniature sensing device.
Oxford Nanopore’s MinION™ USB-attached miniature sensing device. PHOTO: Oxford Nanopore Technologies

The MinION, a handheld DNA-sequencing device developed by Oxford Nanopore, has been tested and evaluated by an independent, international consortium coordinated by EMBL-EBI. The innovative device opens up new possibilities for using sequencing technology in the field, for example in tracking disease outbreaks, testing packaged food or the trafficking of protected species.

The MinION works by detecting individual DNA bases that pass through a nanopore, and unlike existing sequencing technologies, there are few inherent sensing limits on the length of the DNA sequence that it could read at one go. The MinION device was initially made available to thousands of laboratories all over the world, who were inspired to explore the technology and contribute to its development through the MinION Access Programme (MAP).

We’re looking at a democratisation of sequencing in the not-so-distant future.

“The MinION Access Programme was a brilliant thing to do. Because the device weighs only 100 grams, Oxford Nanopore could share it easily with more than 1000 labs worldwide. Some of those people are tinkerers who invented new informatics tools or wet lab techniques that improved MinION performance,” says Mark Akeson of the University of California Santa Cruz, a co-inventor of nanopore sequencing, consultant to Oxford Nanopore, and a MAP participant. “The device performs well now, particularly for viral and bacterial genomes, so you can ship it anywhere and know you’re going to get the same result. We’re looking at a democratisation of sequencing in the not-so-distant future. That is changing things for people who need to solve critical problems in challenging environments, like tracking Ebola strains during the recent outbreak in West Africa. Another challenging environment is space – the MinION will be the first DNA sequencer tested in space, by NASA on the International Space Station.”

Five laboratories in the UK, the US, Canada and The Netherlands conducted two sets of 10 experiments, for the same E. coli isolate (strain K-12 sub-strain MG1655), using a single, shared protocol. The accuracy and reproducibility of the data were consistent between labs and of good quality. However, there is much work to be done in molecule delivery to flow cells, software protocol clarity and other areas.

The data generated in the study published today represents a snapshot of the MinION’s performance in April 2015. Since then, innovation on the MinION has outpaced analysis, with new chips and kits released every 3 to 6 months. The paper, which includes details of the protocol used and preliminary analysis of the data generated, is available in the Nanopore analysis channel on F1000Research. The data are hosted in the European Nucleotide Archive (ENA).

“Oxford Nanopore has excited the world with the promise of a technology that can be truly disruptive,” says David Buck of Oxford University. “When the MinION Access Programme opened it seemed like the largest virtual R&D group ever established in genomics – now the MAP is open to anyone. Working with the MARC team from the start of the MAP has been exciting – we’ve had the chance to push the technology and gain some traction on understanding what is going on under the hood. We’ve published the paper in F1000Research before peer review as a baseline for the community, so that everyone can look at the paper and data, go on to do their own analyses share their results and stimulate discussion.”

“Nanopore sequencing will open the door for the development of novel tools and applications to analyse the influx of new data,” says Rebecca Lawrence, Managing Director of F1000Research. “The Nanopore analysis channel on F1000Research will be a central, open platform on which scientists can publish and discuss new applications and analyse workflows for nanopore sequencing data. People can access and contribute data easily, so that the wider life-science community can realise the full potential of this new technology quickly.”

This new device enables fully mobile sequencing with real-time data streaming

EMBL-EBI has been coordinating the data distribution and analysis for MARC, using the ENA to handle the raw data. “This new device enables fully mobile sequencing with real-time data streaming, which means that with a high-speed Internet connection, the first dataset could arrive 20 minutes after the DNA is loaded,” says Guy Cochrane, who leads the ENA at EMBL-EBI. “The ENA is a public resource that extends the reach and usefulness of sequencing, and with new technologies like this we provide the space, flexibility and expertise needed to test it and get it into shape. We were delighted to use it as the platform for data management and sharing in MAP, so we can place the results in the public domain swiftly.”

The next phase of analysis is already underway by the consortium, which is exploring ways to reduce the error rate and pushing to see how small the sample and how long the reads can be.

Participating organisations

MAP participants are too numerous to list here. Authors on this paper are from the Wellcome Trust Centre for Human Genetics at the University of Oxford, Queens Medical Centre at the University of Nottingham, The Genome Analysis Centre (TGAC), the University of East Anglia and the European Bioinformatics Institute (EMBL-EBI) in the UK; the Malaghan Institute of Medical Research in New Zealand; the University of British Columbia and the Ontario Institute for Cancer Research in Canada; Virginia Commonwealth University, the University of California Santa Cruz, Brown University and Cold Spring Harbor Laboratory in the US; and ZF-screens B.V. in the Netherlands.

Funding and support

This work was funded in part by the Wellcome Trust, Rosetrees Trust, the Biotechnology and Biological Sciences Research Council (BBSRC), the Canadian Institutes of Health Research, the US National Science Foundation, the National Institutes of Health and the National Human Genome Research Institute (NHGRI). Reagents were supplied by Oxford Nanopore Technologies Ltd.

About the MinION Access Programme

The portable MinION device, developed by Oxford Nanopore Technologies Ltd, is a proprietary technology platform for the direct, electronic analysis of single molecules. It works with consumable flow cells that contain the proprietary nanopore sensing apparatus required to perform experiments, and plugs into a PC or laptop that controls the sequencing run. DNA sequencing users generate long reads, analyse data in real-time with a high-speed Internet connection, and use the device in multiple environments. The MinION Access Programme (MAP) is a community-focused technology access programme that started in April 2014 and includes participants in more than 30 countries. Launched as an ‘early-access’ community the MAP seeks to enable a broad range of people to explore how the MinION may be useful to them in nucleic acid analysis, to contribute to developments in analytical tools and applications and to share their experiences and collaborate. The MAP is now open to any registrant.

About the Nanopore analysis channel

F1000Research, launched in 2013, is an open publishing platform for life scientists that offers immediate publication and transparent peer review. F1000Research allows groups to establish their own channels to serve the needs of their community, for example enabling researchers to publish analyses of nanopore sequencing data quickly and easily. This open-science approach facilitates an effective, global, community-wide discussion around the research being produced. The Nanopore analysis channel published on F1000Research features the Phase 1 MARC paper complete with MinION data and a guest editorial. Guest editors of the Nanopore analysis channel are Nick Loman of the University of Birmingham, Matt Loose of the University of Nottingham, Sara Goodwin of Cold Spring Harbour Library and Hans Jansen of ZF-screens B.V.

This post was originally published on EMBL-EBI News.

Tags: bioinformatics, birney, cochrane, embl-ebi, genomics, health, map, marc, minion, oxford nanopore


Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.

EMBLetc. archive

Newsletter archive

Read past editions of our e-newsletter

For press

Contact the Press Office